Shilpa Medicare
Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
DitchCarbon Score
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shilpa Medicare's score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shilpa Medicare's reported carbon emissions
In 2024, Shilpa Medicare reported total carbon emissions of approximately 24,892,210 kg CO2e, comprising about 3,690,310 kg CO2e from Scope 1 and about 20,389,900 kg CO2e from Scope 2 emissions. This reflects a significant increase from 2023, where emissions were approximately 16,220,940 kg CO2e, with Scope 1 emissions at about 1,523,280 kg CO2e and Scope 2 emissions at about 14,691,660 kg CO2e. In 2022, the company reported total emissions of approximately 27,000,000 kg CO2e globally, which included about 3,900,120 kg CO2e from Scope 1, about 22,246,110 kg CO2e from Scope 2, and approximately 877,770 kg CO2e from Scope 3 emissions. The emissions data for 2022 in India mirrored the global figures, with total emissions of about 17,207,840 kg CO2e, consisting of approximately 1,516,970 kg CO2e from Scope 1 and about 15,503,870 kg CO2e from Scope 2. Shilpa Medicare has not set specific reduction targets or climate pledges, and there are no emissions data cascaded from a parent or related organization. The company is actively monitoring its emissions but has not disclosed any formal commitments to reduce its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,900,120 | 0,000,000 | 0,000,000 |
| Scope 2 | 22,246,110 | 00,000,000 | 00,000,000 |
| Scope 3 | 877,770 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shilpa Medicare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
